Isocitrate dehydrogenase mutations in myeloid malignancies

por Medeiros, B C, Fathi, A T, DiNardo, C D, Pollyea, D A, Chan, S M, Swords, R
Publicado 2017

PB1831: UTILITY OF FLT3 INHIBITORS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND T(6;9)(P22;Q34)

por Ong, F., Kadia, T. M., Short, N. J., Yilmaz, M., Alvarado, Y., Pierce, S., Garcia-Manero, G., DiNardo, C., Borthakur, G., Konopleva, M., Daver, N., Kantarjian, H., Ravandi, F.
Publicado 2022